Astellas Pharma, Inc. Financials

Market Capitalization ¥2.491 Trillion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	49.26
Forward PE	18.36
Price to Sales TTM	¥1.30
Price to Book MRQ	¥1.65
Enterprise to Revenue	1.72
Enterprise to EBITDA	7.10

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2024-06-30
Profit Margin	2.65%
Operating Margin	18.53%
Return on Assets TTM	4.77%
Return on Equity TTM	3.26%

Income Statement

Revenue TTM	¥1,912,323,047,424
Revenue per Share TTM	¥1068.22
Quarterly Revenue Growth	10.80%
Gross Profit TTM	¥1,563,116,961,792
EBITDA	¥246,997,000,000
Net Income to Common TTM	¥50,746,998,784
Diluted EPS TTM	¥28.25
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	¥188,371,992,576
Total Cash per Share MRQ	¥105.21
Total Debt MRQ	¥
Total Debt to Equity MRQ	61.93
Current Ratio MRQ	1.13
Book Value per Share MRQ	¥845.21

Cash Flow

Operating Cash Flow TTM	¥194,511,994,880
Levered Free Cash Flow TTM	¥125,259,497,472

4503 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,790,309,954
Float Shares	1,790,146,809
Avg 10 Volume	5,627,210
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.22%
% Held by Institutions	51.32%

Stock Price Summary

Beta	0.12
Fifty Two Week Low	¥1243.50
Fifty Two Week High	¥1835.00
Fifty Two Week Change	-14.80%
Day 50 MA	¥1397.25
Day 200 MA	¥1514.09

Dividends and Splits

Forward Annual Dividend Rate	¥74.00
Forward Annual Dividend Yield	5.28%
Trailing Annual Dividend Rate	¥74.00
Trailing Annual Dividend Yield	5.28%
Payout Ratio	262.04%
Dividend Date
Ex Dividend Date	2025-09-29
Last Split Factor
Last Split Date	2014-03-27